Skip to main content
Clinical Trials/NCT06710912
NCT06710912
Completed
Not Applicable

The Effectiveness of Group Acceptance and Commitment Therapy (ACT) Among Mild to Moderate Depressive Patients in Kelantan, Malaysia

Universiti Sains Malaysia1 site in 1 country44 target enrollmentJune 1, 2022

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Major Depressive Disorder (MDD)
Sponsor
Universiti Sains Malaysia
Enrollment
44
Locations
1
Primary Endpoint
Depressive symptoms
Status
Completed
Last Updated
last year

Overview

Brief Summary

The goal of this clinical trial is to learn if group acceptance and commitment therapy works to improve depressive symptoms, psychological flexibility and quality of life in adults. The main questions it aims to answer are:

  1. What is the effectiveness of group Acceptance and Commitment Therapy (ACT) in reducing depressive symptoms among depressive patients in Kelantan from pre- to post-intervention and at 3 months follow-up?
  2. What is the mean difference of quality of life among depressive patients in Kelantan who undergo group ACT from pre- to post-intervention and at 3 months follow-up?
  3. What is the effectiveness of group ACT in improving the psychological flexibility among depressive patients in Kelantan from pre- to post intervention and at 3 months follow-up?

Researchers will compare group ACT group to a treatment-as-usual (TAU) group to see if group ACT works to improve depressive symptoms, quality of life and psychological flexibility.

Participants will:

  • Attend weekly ACT sessions for four weeks or undergo standard treatment for major depressive disorder.
  • Fill up four questionnaires before the intervention, after a month and at 3-month follow-up.

Detailed Description

General Objectives To study the effectiveness of group Acceptance and Commitment Therapy in the treatment of depression among depressive patients in Kelantan. Specific Objectives 1. To evaluate the effectiveness of group Acceptance and Commitment Therapy (ACT) in reducing the symptoms of depression in patients in Kelantan from pre- to post-intervention and at 3 months follow-up. 2. To determine the effectiveness of group Acceptance and Commitment Therapy (ACT) in improving the quality of life of patients with depression in Kelantan from pre- to post-intervention and at 3 months follow-up. 3. To assess the effectiveness of group Acceptance and Commitment Therapy (ACT) in improving the psychological flexibility of patients with depression in Kelantan from pre- to post intervention and at 3 months follow-up. This quasi-experimental study used a two-group design, comparing group ACT with TAU at baseline, post-intervention, and a 3-month follow-up. Conducted at the Psychiatry Clinic, Hospital Universiti Sains Malaysia, from June 2022 to May 2024, the study included 44 participants with mild to moderate depression. Twenty-two participants allocated in the ACT group received weekly group ACT sessions over four weeks, while twenty-two participants were assigned to the TAU group. Outcomes were measured using the Malay versions of the Beck Depression Inventory I (BDI), WHO Quality of Life-BREF (WHOQOL-BREF), and Acceptance and Action Questionnaire II (AAQ-II) at baseline, post-intervention, and at 3-month follow-up. Data was analyzed using two-way Repeated Measures Analysis of Variance (RM ANOVA) to assess changes in these outcomes across the different time points.

Registry
clinicaltrials.gov
Start Date
June 1, 2022
End Date
May 31, 2024
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Aisyah Che Rahimi

Dr

Universiti Sains Malaysia

Eligibility Criteria

Inclusion Criteria

  • had a Beck Depression Inventory (BDI) score ranging from 10 to 29, indicating mild to moderate depression.
  • Proficient in the Malay language
  • Willing to commit to the study.

Exclusion Criteria

  • Have concomitant psychotic symptoms.
  • Participated and enrolled in Cognitive Behavioural Therapy.
  • previously had participated in Acceptance Commitment Therapy.
  • had underlying substance use disorder or active substance use.

Outcomes

Primary Outcomes

Depressive symptoms

Time Frame: From enrollment to the end of treatment at 4 weeks

The outcome was measured by using Beck Depression Inventory (BDI)

Quality of life

Time Frame: From enrollment to the end of treatment at 4 weeks

The outcome was measured by using brief WHO Quality of Life (WHOQOL) questionnaire (Malay version)

Psychological flexibility

Time Frame: From enrollment to the end of treatment at 4 weeks

The outcome was measured using Acceptance and Action Questionnaire II Malay Version (AAQ-II)

Secondary Outcomes

  • Depressive symptoms (3 months)(3 months post intervention)
  • Quality of life (3 months)(3 months post intervention)
  • Psychological flexibility (3 months)(3 months post intervention)

Study Sites (1)

Loading locations...

Similar Trials